Deutsche Bank’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Deutsche Bank's TAK Position: Q3 2026 in Review
Deutsche Bank sold out of Takeda Pharmaceutical (TAK) in Q3 2026, closing a stake of 120 shares — an estimated $1.92K sold.
Deutsche Bank first reported a position in TAK in Q1 2019 and held it in 18 quarters. The position peaked at $5.48M in Q4 2019. 396 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Deutsche Bank reported no remaining Takeda Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Deutsche Bank sold 120 Takeda Pharmaceutical shares in Q3 2026, an estimated $1.92K.
- Deutsche Bank first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 18 quarters.
- Deutsche Bank's Takeda Pharmaceutical position peaked at $5.48M in Q4 2019.
- 396 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.